MACRODANTIN

This brand name is authorized in Australia, Cyprus, Ireland, Malta, United States, South Africa

Active ingredients

The drug MACRODANTIN contains one active pharmaceutical ingredient (API):

1 Nitrofurantoin UNII 927AH8112L - NITROFURANTOIN

Nitrofurantoin is a broad spectrum antibacterial agent, active against the majority of urinary pathogens. It is bactericidal in renal tissue and throughout the urinary tract. The wide range of organisms sensitive to the bacterial activity include Escherichia coli, Enteroccus faecalis, Klebsiella species, Enterobacter species, Staphylococcus species: (e.g. S. aureus, S. saprophyticus, S. epidermidis). Read about Nitrofurantoin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MACRODANTIN Capsule	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XE01	Nitrofurantoin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XE Nitrofuran derivatives
Discover more medicines within J01XE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1692C, 1693D
Country: IE	Health Products Regulatory Authority	Identifier(s): 59641, 59672
Country: MT	Medicines Authority	Identifier(s): MA625/00501, MA625/00502
Country: US	FDA, National Drug Code	Identifier(s): 52427-286, 52427-287, 52427-288
Country: ZA	Health Products Regulatory Authority	Identifier(s): G/18.5/161